These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14748788)

  • 21. [The 1992 TNM classification of T2 prostate cancer predicts pathologic stage and prognosis better than the revised 1997 classification].
    Koh H; Maru N; Muramoto M; Wheeler TM; Scardino PT; Ohori M
    Nihon Hinyokika Gakkai Zasshi; 2002 Jul; 93(5):595-601. PubMed ID: 12174634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.
    Bozlu M; Orhan D; Baltaci S; Yaman O; Elhan AH; Tulunay O; Müftüoğlu YZ
    Int Urol Nephrol; 2002; 33(1):59-66. PubMed ID: 12090340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of p53, proliferating cell nuclear antigen, and Ki-67 expression in undifferentiated nasopharyngeal carcinomas.
    Genç E; Hoşal AS; Gedikoğlu G; Ozyar E; Sözeri B
    Otolaryngol Head Neck Surg; 2000 Jun; 122(6):868-73. PubMed ID: 10828801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p120 and AgNOR nucleolar protein expression: a comparison with nuclear proliferation markers in oral pathology.
    Migaldi M; Criscuolo M; Zunarelli E; Lo Bianco L; Martinelli AM; Barbolini G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Feb; 85(2):189-96. PubMed ID: 9503455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma.
    Visakorpi T
    J Pathol; 1992 Sep; 168(1):7-13. PubMed ID: 1360498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferating cell nuclear antigen/cyclin in incidental carcinoma of the prostate.
    Botticelli AR; Criscuolo M; Martinelli AM; Botticelli L; Filoni A; Migaldi M
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):365-8. PubMed ID: 7906910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1-2M0 prostatic adenocarcinoma.
    Vesalainen SL; Lipponen PK; Talja MT; Alhava EM; Syrjänen KJ
    Int J Cancer; 1994 Jul; 58(2):303-8. PubMed ID: 7913085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
    Sebo TJ; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Myers RP; Blute ML; Zincke H
    Cancer; 2001 Jun; 91(11):2196-204. PubMed ID: 11391602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
    Narita T; Funahashi H; Satoh Y; Takagi H
    Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS
    Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy.
    May M; Siegsmund M; Hammermann F; Loy V; Gunia S
    Scand J Urol Nephrol; 2007; 41(5):375-81. PubMed ID: 17853019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma.
    Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Shirakawa H; Ishibe T; Shirakawa R; Nagasaki M; Shirane T; Usui T
    Prostate; 1997 Jun; 32(1):49-58. PubMed ID: 9207957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
    Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
    J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific?
    Choong PF; Akerman M; Willén H; Andersson C; Gustafson P; Alvegård T; Rydholm A
    APMIS; 1995 Nov; 103(11):797-805. PubMed ID: 8546844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferating cell nuclear antigen in needle biopsy specimens of prostatic carcinoma.
    Naito S; Sakamoto N; Kotoh S; Goto K; Koga H; Hasegawa S; Matsumoto T; Kumazawa J
    Eur Urol; 1994; 26(2):164-9. PubMed ID: 7525294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.
    Aaltomaa S; Kärjä V; Lipponen P; Isotalo T; Kankkunen JP; Talja M; Mokka R
    Anticancer Res; 2006; 26(6C):4873-8. PubMed ID: 17214354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
    Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
    Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.
    Claudio PP; Zamparelli A; Garcia FU; Claudio L; Ammirati G; Farina A; Bovicelli A; Russo G; Giordano GG; McGinnis DE; Giordano A; Cardi G
    Clin Cancer Res; 2002 Jun; 8(6):1808-15. PubMed ID: 12060621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.